Enzymatic Therapy, Inc. Surpasses New FDA CGMP Standards

GREEN BAY, Wis.--(BUSINESS WIRE)--Enzymatic Therapy, Inc. (ETI), the manufacturer and marketer of branded natural medicines, strongly supports the Current Good Manufacturing Practices (CGMPs) that were passed by the FDA this week. ETI has been operating its manufacturing facility to even stricter Drug GMP principles since it was built nearly 10 years ago. Proud to be both an FDA registered drug establishment and an organically certified processor, ETI sets the gold standard for dietary supplement quality in the industry.

MORE ON THIS TOPIC